February 8, 2016
Recommended Topic Related To:

Natrecor

"The U.S. Food and Drug Administration today approved the Impella 2.5 System, a miniature blood pump system intended to help certain patients maintain stable heart function and circulation during certain high-risk percutaneous coronary interventio"...

A A A

Natrecor




PATIENT INFORMATION

Advise patients of the potential benefits and risks of NATRECOR®. Advise patients to notify their physician or healthcare professional if they have symptoms of hypotension [see WARNINGS AND PRECAUTIONS].

Last reviewed on RxList: 9/4/2012
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Heart Health

Get the latest treatment options.

Atrial Fibrillation Quiz